Positive EMA Scientific Advice Positions GeoVax for Expedited European Approval ATLANTA, GA - July 21, 2025 (NEWMEDIAWIRE) - ...

European Medicines Agency Supports Streamlined Development Pathway for GEO-MVA Vaccine Candidate via a Single Phase 3 ...

ATLANTA, GA - June 25, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing multi-antigen vaccines and immunotherapies against infectious diseases and cancers, ...

GeoVax’s development-stage continuous avian cell line process is anticipated to provide increased production of MVA-based vaccines, the ability to quickly respond to epidemics and pandemics ...

As lawmakers weigh potential cuts to scientific research funding, the outlook for developing cancer cures faces growing ...

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research ...

A high-level overview of GeoVax Labs, Inc. WT EXP 092925 (GOVXW) stock. View (GOVXW) real-time stock price, chart, news, analysis, analyst reviews and more.

Review quarterly and annual revenue, net income, and cash flow for Geovax Labs Inc (GOVX:XNAS) stock through the last fiscal year.

Review the current Geovax Labs Inc (GOVX:XNAS) dividend yield and history to decide if GOVX is the best investment for you.

View the latest GeoVax Labs Inc. Wt (GOVXW) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Find the latest GeoVax Labs, Inc. (GOVX) stock quote, history, news and other vital information to help you with your stock trading and investing.

US stock market today saw mixed moves as the S&P 500 and Nasdaq pulled back from recent highs while the Dow Jones climbed.